These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28600225)

  • 1. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer.
    Shen L; Qian Y; Wu W; Weng T; Wang FXC; Hong B; Wu Z; Wang Q; Sang Y; Zhang H; Zhou X; Yao H
    Hum Pathol; 2017 Aug; 66():79-85. PubMed ID: 28600225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases.
    Qian Y; Sang Y; Wang FX; Hong B; Wang Q; Zhou X; Weng T; Wu Z; Zheng M; Zhang H; Yao H
    Oncotarget; 2016 Nov; 7(44):72242-72249. PubMed ID: 27750217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases.
    Liang L; Jiang Y; Chen JS; Niu N; Piao J; Ning J; Zu Y; Zhang J; Liu J
    Hum Pathol; 2016 Nov; 57():1-6. PubMed ID: 27349304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma.
    Fan M; Zhuang Q; Chen Y; Ding T; Yao H; Chen L; He X; Xu X
    Int J Clin Exp Pathol; 2014; 7(10):6768-75. PubMed ID: 25400757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.
    Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J
    Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.
    Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S
    World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma.
    Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S
    Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer.
    Huang H; Li C; Ren G
    Gene; 2017 Aug; 623():24-28. PubMed ID: 28412458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration.
    Zhao LW; Li C; Zhang RL; Xue HG; Zhang FX; Zhang F; Gai XD
    Acta Histochem; 2014 Sep; 116(7):1163-8. PubMed ID: 25053455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-H4 expression is associated with tumor progression and prognosis in patients with osteosarcoma.
    Dong Q; Ma X
    Biomed Res Int; 2015; 2015():156432. PubMed ID: 25954746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H4 is a potential prognostic biomarker of prostate cancer.
    Li H; Piao L; Liu S; Cui Y; Xuan Y
    Exp Mol Pathol; 2020 Jun; 114():104406. PubMed ID: 32088189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma.
    Zhang H; Gao H; Liu C; Kong Y; Wang C; Zhang H
    Diagn Pathol; 2015 Mar; 10():13. PubMed ID: 25890028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H3 and B7-H4 are independent predictors of a poor prognosis in patients with pancreatic cancer.
    Xu H; Chen X; Tao M; Chen K; Chen C; Xu G; Li W; Yuan S; Mao Y
    Oncol Lett; 2016 Mar; 11(3):1841-1846. PubMed ID: 26998087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of B7-H4 is associated with infiltrating immune cells and poor prognosis in metastatic colorectal cancer.
    Ding S; Lv X; Liu Z; Zhan S; Xu Y; Zhang X; Liu C; Cao L
    Int Immunopharmacol; 2021 Jan; 90():107144. PubMed ID: 33187907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
    Tan Z; Shen W
    Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.
    Geng Y; Wang H; Lu C; Li Q; Xu B; Jiang J; Wu C
    Int J Clin Oncol; 2015 Apr; 20(2):273-81. PubMed ID: 24804867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
    World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of anti-B7-H4 monoclonal antibody to investigate B7-H4 expression in pancreatic cancer].
    Hong B; Qian Y; Yao HP
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 42(5):511-6. PubMed ID: 24167131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.